Teasing Apart Multiple Biologic Failure in Psoriasis, PsA :

'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'

Related Keywords

San Francisco , California , United States , France , Washington , French , Christophert Ritchlin , Trex Bio , Wilson Liao , Amgen , American College Of Rheumatology , Pfizer , Skin Treatment Center , University Of Rochester , Musculoskeletal Research , University Of California , National Psoriasis Foundation , Novartis , National Psoriasis , Skin Treatment , Psoriasis Area , Severity Index , Corevitas Psoriasis Registry , American College , Psoriasis , Prostate Specific Antigen Psa , Prostate Specific Antigen , Sa , Biologic Therapy , Psoriatic Arthritis , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Prostate , Genetics , Refractory , Health Insurance , Arthritis , Oint Inflammation , Human Leukocyte Antigen , La Human Leukocyte Antigen , Hyperlipidemia , Insurance , Metabolism , Etabolic , Spain , Adherence , Dherence To Medicat ,